Bristol Myers signs deal with Janux on T cell engager for $50M upfront
Bristol Myers signs deal with Janux on T cell engager for $50M upfront
本文は利用できません。元の情報源をご確認ください。
Bristol Myers signs deal with Janux on T cell engager for $50M upfront
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.